This week, I was making a presentation for Company X and needed to keep abreast of the recent cost per genome figure computed at genome.gov. Well, thanks to a retweet by Michael, it looks like October 1 saw the Second Inflection point we've been waiting for. Time to change the slides and time to think about The Important Things after Commodity Sequencing.
Related:
Let us note that this cost figure still doesn't seem to include neither Pacific BioSciences RSII nor Oxford Nanopore technology cost.
Related:
Liked this entry ? subscribe to Nuit Blanche's feed, there's more where that came from. You can also subscribe to Nuit Blanche by Email, explore the Big Picture in Compressive Sensing or the Matrix Factorization Jungle and join the conversations on compressive sensing, advanced matrix factorization and calibration issues on Linkedin.
No comments:
Post a Comment